Daewoong Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014

Date: March 31, 2014
Pages: 67
Price:
US$ 1,500.00 US$ 1,125.00
Offer valid until December 31, 2016!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: D1F7526B148EN
Leaflet:

Download PDF Leaflet

Summary

Global Markets Direct’s, ‘Daewoong Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014’, provides an overview of the Daewoong Pharmaceutical Co., Ltd.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Daewoong Pharmaceutical Co., Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides brief overview of Daewoong Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Daewoong Pharmaceutical Co., Ltd.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Daewoong Pharmaceutical Co., Ltd.’s pipeline products
Reasons to buy
  • Evaluate Daewoong Pharmaceutical Co., Ltd.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Daewoong Pharmaceutical Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Daewoong Pharmaceutical Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Daewoong Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Daewoong Pharmaceutical Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Daewoong Pharmaceutical Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues
Daewoong Pharmaceutical Co., Ltd. Snapshot
Daewoong Pharmaceutical Co., Ltd. Overview
Key Information
Key Facts
Daewoong Pharmaceutical Co., Ltd. - Research and Development Overview
Key Therapeutic Areas
Daewoong Pharmaceutical Co., Ltd. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Daewoong Pharmaceutical Co., Ltd. - Pipeline Products Glance
Daewoong Pharmaceutical Co., Ltd. - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Daewoong Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Daewoong Pharmaceutical Co., Ltd. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Daewoong Pharmaceutical Co., Ltd. - Unknown Stage Pipeline Products
Unknown Products/Combination Treatment Modalities
Daewoong Pharmaceutical Co., Ltd. - Drug Profiles
aclidinium bromide
Product Description
Mechanism of Action
R&D Progress
(rosuvastatin calcium + olmesartan medoxomil)
Product Description
Mechanism of Action
R&D Progress
DWJ-1261
Product Description
Mechanism of Action
R&D Progress
IMD-4
Product Description
Mechanism of Action
R&D Progress
nepidermin
Product Description
Mechanism of Action
R&D Progress
onabotulinumtoxinA biosimilar
Product Description
Mechanism of Action
R&D Progress
DWP-05195
Product Description
Mechanism of Action
R&D Progress
DWJ-204
Product Description
Mechanism of Action
R&D Progress
DWP-09031
Product Description
Mechanism of Action
R&D Progress
DWP-10292
Product Description
Mechanism of Action
R&D Progress
DWP-418
Product Description
Mechanism of Action
R&D Progress
etanercept biosimilar
Product Description
Mechanism of Action
R&D Progress
DWJ-1308
Product Description
Mechanism of Action
R&D Progress
DWJ-1325
Product Description
Mechanism of Action
R&D Progress
DWJ-206
Product Description
Mechanism of Action
R&D Progress
DWJ-208
Product Description
Mechanism of Action
R&D Progress
DWJ-800
Product Description
Mechanism of Action
R&D Progress
DWP-451
Product Description
Mechanism of Action
R&D Progress
DWP-455
Product Description
Mechanism of Action
R&D Progress
DWJ-1330
Product Description
Mechanism of Action
R&D Progress
DWJ-1340
Product Description
Mechanism of Action
R&D Progress
DWJ-1341
Product Description
Mechanism of Action
R&D Progress
DWJ-205
Product Description
Mechanism of Action
R&D Progress
DWJ-209
Product Description
Mechanism of Action
R&D Progress
Undisclosed Program
Product Description
Mechanism of Action
R&D Progress
(aclidinium bromide + formoterol fumarate)
Product Description
Mechanism of Action
R&D Progress
Daewoong Pharmaceutical Co., Ltd. - Pipeline Analysis
Daewoong Pharmaceutical Co., Ltd. - Pipeline Products by Target
Daewoong Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration
Daewoong Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type
Daewoong Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action
Daewoong Pharmaceutical Co., Ltd. - Recent Pipeline Updates
Daewoong Pharmaceutical Co., Ltd. - Dormant Projects
Daewoong Pharmaceutical Co., Ltd. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
lagociclovir
Daewoong Pharmaceutical Co., Ltd. - Company Statement
Daewoong Pharmaceutical Co., Ltd. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Daewoong Pharmaceutical Co., Ltd., Key Information
Daewoong Pharmaceutical Co., Ltd., Key Facts
Daewoong Pharmaceutical Co., Ltd. - Pipeline by Indication, 2014
Daewoong Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014
Daewoong Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014
Daewoong Pharmaceutical Co., Ltd. - Combination Treatment Modalities in Pipeline, 2014
Daewoong Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2014
Daewoong Pharmaceutical Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2014
Daewoong Pharmaceutical Co., Ltd. - Pre-Registration, 2014
Daewoong Pharmaceutical Co., Ltd. - Phase III, 2014
Daewoong Pharmaceutical Co., Ltd. - Phase II, 2014
Daewoong Pharmaceutical Co., Ltd. - Phase I, 2014
Daewoong Pharmaceutical Co., Ltd. - Preclinical, 2014
Daewoong Pharmaceutical Co., Ltd. - Discovery, 2014
Daewoong Pharmaceutical Co., Ltd. - Unknown, 2014
Daewoong Pharmaceutical Co., Ltd. - Pipeline by Target, 2014
Daewoong Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2014
Daewoong Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2014
Daewoong Pharmaceutical Co., Ltd. - Pipeline Products by Mechanism of Action, 2014
Daewoong Pharmaceutical Co., Ltd. - Recent Pipeline Updates, 2014
Daewoong Pharmaceutical Co., Ltd. - Dormant Developmental Projects,2014
Daewoong Pharmaceutical Co., Ltd. - Discontinued Pipeline Products, 2014
Daewoong Pharmaceutical Co., Ltd., Other Locations

LIST OF FIGURES

Daewoong Pharmaceutical Co., Ltd. - Pipeline by Top 10 Indication, 2014
Daewoong Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014
Daewoong Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014
Daewoong Pharmaceutical Co., Ltd. - Combination Treatment Modalities in Pipeline, 2014
Daewoong Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2014
Daewoong Pharmaceutical Co., Ltd. - Pipeline by Top 10 Target, 2014
Daewoong Pharmaceutical Co., Ltd. - Pipeline by Top 10 Route of Administration, 2014
Daewoong Pharmaceutical Co., Ltd. - Pipeline by Top 10 Molecule Type, 2014
Daewoong Pharmaceutical Co., Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2014
Skip to top


Ask Your Question

Daewoong Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: